Sophie Schröder

German Center for Neurodegenerative Diseases

Biochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency”.

Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency

EMBO Molecular Medicine(2023)10.15252/emmm.202114837

N/A

0.651DataRank · unranked

17 citations

Karolina Tyka, Matthias Kettwig, Rebecca C. Ahrens‐Nicklas, Matthias G. J. Baud, Tea Berulava +16 more

PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimer’s disease

Acta Neuropathologica(2024)10.1007/s00401-024-02787-x

N/A

0DataRank · unranked

17 citations

Ulrike Fuchs, Verena Gisa, Tonatiuh Peña, D. Krüger, Nina Hempel +7 more

PRDM16-DT: A Brain and Astrocyte-Specific lncRNA Implicated in Alzheimer’s Disease

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.06.27.600964

N/A

0DataRank · unranked

4 citations

Ulrike Fuchs, Verena Gisa, Tonatiuh Peña, D. Krüger, Nina Hempel +7 more